Inactive Instrument

Calendar Enzymatica AB Nasdaq Stockholm

Equities

SE0003943620

Chart calendar Enzymatica AB

e2b6601ff.aLnTztte9C9o2EHHQcBbtYfLGNeAUK3ipLpY75YslGs.Cte4qIxqmxcwgRSrdZY58N6CUefXGNS64tkxjdJnpT4LgLCdmTm3RQDqIg~6748cea6589ca57fd9c72d66153086fe

Upcoming events on Enzymatica AB

2024-04-25 02:30 am Q1 2024 Earnings Release
2024-05-07 08:30 am Annual General Meeting
2024-07-18 02:30 am Q2 2024 Earnings Release
2024-11-07 02:30 am Q3 2024 Earnings Release
2025-02-18 02:30 am Q4 2024 Earnings Release
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-07-16 Q2 2025 Earnings Release (Projected)
2025-11-10 Q3 2025 Earnings Release (Projected)
2026-02-11 Q4 2025 Earnings Release (Projected)

Past events on Enzymatica AB

2024-02-16 02:30 am Q4 2023 Earnings Release
2023-11-06 Q3 2023 Earnings Release
2023-07-17 Q2 2023 Earnings Release
2023-05-04 08:30 am Annual General Meeting
2023-04-27 02:59 am Q1 2023 Earnings Release
2023-02-17 03:13 am FY 2022 Earnings Release
2022-11-02 03:55 am Q3 2022 Earnings Release
2022-10-25 Redeye Medtech Seminar 2022
2022-07-19 02:57 am Interim 2022 Earnings Release
2022-04-28 08:30 am Annual General Meeting
2022-04-28 02:30 am Q1 2022 Earnings Release
2022-02-17 02:43 am FY 2021 Earnings Release
2021-11-02 04:04 am Q3 2021 Earnings Release
2021-07-16 03:14 am Interim 2021 Earnings Release
2021-05-05 08:30 am Annual General Meeting
2021-04-29 02:49 am Q1 2021 Earnings Release
2021-02-18 03:14 am FY 2020 Earnings Release
2020-11-03 03:10 am Q3 2020 Earnings Release
2020-07-16 03:03 am Interim 2020 Earnings Release
2020-05-05 08:30 am Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
6,37
6,79
-6.26%
13,3
12,8
4.48%
6,17
7,42
-16.94%
4,67
5,43
-14.02%
4,87
4,87
0.1%

7,14

EBITDA
Million USD
Released
Forecast
Spread
-3,42
-3,76
9.02%
-0,58
-0,67
14.01%
-4,14
-4,14
0.13%
-5,82
-4,59
-26.66%
0,00
0,00
-

-3,21

EBIT
Million USD
Released
Forecast
Spread
-4,33
-4,39
1.31%
-1,45
-1,04
-39.38%
-4,87
-4,62
-5.5%
-6,50
-4,88
-33.25%
-4,60
-3,90
-17.96%

-3,31

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,34
-4,49
3.5%
-1,57
-1,12
-39.89%
-4,92
-4,68
-5.1%
-6,55
-4,93
-33.07%
-4,76
-4,04
-17.86%

-3,41

Net income
Million USD
Released
Forecast
Spread
-4,26
-4,60
7.37%
-1,58
-0,88
-80.85%
-4,89
-4,59
-6.46%
-6,55
-4,93
-32.91%
-4,76
-4,02
-18.43%

-3,41

EPS
USD
Released
Forecast
Spread
-0,03
-0,03
5.84%
-0,01
-0,01
-35%
-0,03
-0,03
-6.03%
-0,04
-0,03
-44.66%
0,00
0,00
-

-0,02

Announcement Date13/02/2018/02/2117/02/2217/02/2316/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
2,02
3,11
-35.03%
0,42
1,86
-77.23%
0,93
0,81
14.55%
1,68


1,59
2,36
-32.8%
1,26
1,54
-18.15%
0,86
0,69
24.49%
1,22
1,78
-31.51%
1,52
1,66
-8.82%

1,59


1,11


2,22


3,02

EBITDA
Million USD
Released
Forecast
Spread
-0,95
-0,47
-103.84%
-1,68
-0,86
-95.63%
-1,41
-1,52
7.22%






























EBIT
Million USD
Released
Forecast
Spread
-1,14
-0,72
-56.81%
-1,84
-0,97
-90.71%
-1,54
-1,73
10.98%



-2,06
-0,70
-192.58%



-1,09
-1,31
16.6%
-0,80
-1,31
38.78%
-1,32
-0,77
-71.82%

-1,19


-1,02


-0,87


-0,80

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,15
-0,82
-40.75%
-1,84
-1,07
-71.35%
-1,52
-1,80
15.43%






























Net income
Million USD
Released
Forecast
Spread
-1,16
-0,78
-48.05%
-1,83
-1,07
-70.77%
-1,48
-1,79
16.86%






























EPS
USD
Released
Forecast
Spread
-0,01
0,00
-




































Announcement Date17/02/2228/04/2219/07/2202/11/2217/02/2327/04/2318/07/2307/11/2316/02/24----